Clinical scoring system for the prediction of target site penetration of antimicrobials in patients with sepsis

Clinical Pharmacokinetics

Volumn 46, Issue 1, 2007, Pages 75-83

  Zeitlinger, Barbara S ^a   Zeitlinger, Markus ^a   Leitner, Irmgard ^a   Müller, Markus ^a   Joukhadar, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFPIROME; FOSFOMYCIN; LACTIC ACID; LEVOFLOXACIN; NORADRENALIN; PIPERACILLIN;

AREA UNDER THE CURVE; ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MUSCLE LEVEL; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; HUMAN; INTENSIVE CARE; LACTATE BLOOD LEVEL; MICRODIALYSIS; MORTALITY; MUSCLE TISSUE; OXYGEN SATURATION; PRIORITY JOURNAL; SCORING SYSTEM; SEPSIS; SINGLE DRUG DOSE; SKELETAL MUSCLE; SOFT TISSUE; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; HUMANS; MICRODIALYSIS; MUSCLE, SKELETAL; SEPSIS; TISSUE DISTRIBUTION;

EID: 33846140848     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200746010-00004     Document Type: Article

References (25)

1. Brun-Buisson C, Meshaka P, Pinton P, et al. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004 Apr; 30 (4): 580-8
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001 Jul; 29 (7): 1303-10
3. Ryan DM. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother 1993 May; 31 Suppl. D: 1-16
4. Zeitlinger MA, Dehghanyar P, Mayer BX, et al. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother 2003 Nov; 47 (11): 3548-53
5. Baddour LM, Yu VL, Klugman KP, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 2004 Aug 15; 170 (4): 440-4
6. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003 Dec; 31 (12): 2742-51
7. Le Gall JR, Loirat P, Alperovitch A, et al. A simplified acute physiology score for ICU patients. Crit Care Med 1984 Nov; 12 (11): 975-7
8. Moreno RP, Metnitz PG, Almeida E, et al. SAPS 3: from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 2005 Oct; 31 (10): 1345-55
9. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993 Dec 22-29; 270 (24): 2957-63
10. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985 Oct; 13 (10): 818-29
11. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991 Dec; 100 (6): 1619-36
12. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996 Jul; 22 (7): 707-10
13. Baumgartner JD, Bula C, Vaney C, et al. A novel score for predicting the mortality of septic shock patients. Crit Care Med 1992 Jul; 20 (7): 953-60
14. Fry DE. The importance of antibiotic pharmacokinetics in critical illness. Am J Surg 1996 Dec; 172 (6A): 20S-5S
15. Muller M, Haag O, Burgdorff T, et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother 1996 Dec; 40 (12): 2703-9
16. Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 2001 Feb; 29 (2): 385-91
17. Joukhadar C, Klein N, Dittrich P, et al. Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother 2003 May; 51 (5): 1247-52
18. Joukhadar C, Klein N, Mayer BX, et al. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med 2002 Jul; 30 (7): 1478-82
19. Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Crit Care Med 1992 Jun; 20 (6): 724-6
20. Joukhadar C, Derendorf H, Muller M. Microdialysis: a novel tool for clinical studies of anti-infective agents. Eur J Clin Pharmacol 2001 Jun; 57 (3): 211-9
21. Lonnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987 Aug; 253 (2 Pt 1): E228-31
22. Zeitlinger MA, Erovic BM, Sauermann R, et al. Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis. J Antimicrob Chemother 2005 Oct; 56 (4): 703-8
23. NCCLS. Document M23-A2: development of in vitro susceptibility testing criteria and quality control parameters: approved guideline. 2nd ed. Wayne (PA): Clinical and Laboratory Standards Institute (CLSI), 2001
24. Levy B, Gibot S, Franck P, et al. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 2005 Mar 5-11; 365 (9462): 871-5
25. Luchette F, Jenkins W, Friend L, et al. Hypoxia is not the sole cause of lactate production during shock. J Trauma 2002; 52 (3): 415-9